1. Home
  2. BZH vs NUVB Comparison

BZH vs NUVB Comparison

Compare BZH & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BZH
  • NUVB
  • Stock Information
  • Founded
  • BZH 1985
  • NUVB 2018
  • Country
  • BZH United States
  • NUVB United States
  • Employees
  • BZH N/A
  • NUVB N/A
  • Industry
  • BZH Homebuilding
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • BZH Consumer Discretionary
  • NUVB Health Care
  • Exchange
  • BZH Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • BZH 747.9M
  • NUVB 837.0M
  • IPO Year
  • BZH 1994
  • NUVB N/A
  • Fundamental
  • Price
  • BZH $26.24
  • NUVB $3.89
  • Analyst Decision
  • BZH Strong Buy
  • NUVB Strong Buy
  • Analyst Count
  • BZH 3
  • NUVB 6
  • Target Price
  • BZH $32.00
  • NUVB $8.00
  • AVG Volume (30 Days)
  • BZH 362.4K
  • NUVB 6.2M
  • Earning Date
  • BZH 07-31-2025
  • NUVB 11-05-2025
  • Dividend Yield
  • BZH N/A
  • NUVB N/A
  • EPS Growth
  • BZH N/A
  • NUVB N/A
  • EPS
  • BZH 2.23
  • NUVB N/A
  • Revenue
  • BZH $2,385,816,000.00
  • NUVB $14,355,000.00
  • Revenue This Year
  • BZH N/A
  • NUVB $332.80
  • Revenue Next Year
  • BZH $6.03
  • NUVB $360.12
  • P/E Ratio
  • BZH $11.75
  • NUVB N/A
  • Revenue Growth
  • BZH 9.97
  • NUVB 900.35
  • 52 Week Low
  • BZH $17.37
  • NUVB $1.54
  • 52 Week High
  • BZH $38.22
  • NUVB $4.09
  • Technical
  • Relative Strength Index (RSI)
  • BZH 60.83
  • NUVB 83.37
  • Support Level
  • BZH $24.52
  • NUVB $2.87
  • Resistance Level
  • BZH $25.54
  • NUVB $3.08
  • Average True Range (ATR)
  • BZH 0.83
  • NUVB 0.22
  • MACD
  • BZH 0.01
  • NUVB 0.08
  • Stochastic Oscillator
  • BZH 72.35
  • NUVB 86.52

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: